会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PYRIDINE AMIDE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS
    • 吡啶酰胺衍生物作为EP4受体拮抗剂
    • WO2012076063A1
    • 2012-06-14
    • PCT/EP2010/069355
    • 2010-12-10
    • ROTTAPHARM S.P.A.BORRIELLO, ManuelaROVATI, LucioSTASI, Luigi PieroBUZZI, BenedettaCOLACE, Fabrizio
    • BORRIELLO, ManuelaROVATI, LucioSTASI, Luigi PieroBUZZI, BenedettaCOLACE, Fabrizio
    • C07D401/04C07D401/14C07D413/14A61K31/4439A61P29/00
    • C07D413/14C07D401/04C07D401/14
    • The invention relates pyridine amide derivative of Formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 and R 2 are independently hydrogen, linear o branched (C1-C3)alkyl or joined together they form a cyclopropyl ring; R is independently selected from the group consisting of halogens and trifluoromethyl and p is 1, 2 or 3; A is C or N; E is a group of formula (B) or (C), wherein B is C(O)OH, C(O)O(C1-C3)alkyl, and C is selected from the group consisting of formula (I) m is 1,2 or 3, n is 0 or 1, W is -O-, -O(C1-C3 alkyl)-; -(C1-C3 alkyl)O-; -C(O)-; -C(=N-O(C1-C3 alkyl))-; -NH- or -NH(C1-C3alkyl)-; Ar is phenyl, optionally substituted with one or more substituents selected from the group consisting of halogen, trifluoromethyl, trifluoromethoxy, methyl, -NH(C1-C3alkyl)-; -N(C1-C3alkyl)(C1-C3alkyl)-, a from 5 to 7 membered heterocyclic ring containing one nitrogen atom which is convalently bonded to Ar and optionally containing one or two heteroatoms selected from N, O and S; and a 5- or 6-membered heteroaromatic ring containing 1 to 3 heteroatoms selected from S, O e N, such heteroaromatic ring being substituted with one or two substituents selected from the group consisting of (C1-C3)alkyl, (C3-C5)cycloalkyloxy, (C1-C3)alkylcarbonyl. The compounds of the invention could be used for manufacturing a medicament for the treatment of pathologies which require the use of an antagonist of the EP4 receptor, such as the treatment of acute and chronic pain, inflammatory pain, osteoarthritis, inflammation-associated disorder as arthritis, rheumatoid artrhritis, cancer, endometriosis and migraine.
    • 本发明涉及式(I)的吡啶酰胺衍生物或其药学上可接受的盐,其中R 1和R 2独立地为氢,直链或支链(C 1 -C 3)烷基或连接在一起形成环丙基环; R独立地选自卤素和三氟甲基,p是1,2或3; A是C或N; E是式(B)或(C)的基团,其中B是C(O)OH,C(O)O(C1-C3)烷基,C选自式(I) 1,2或3,n为0或1,W为-O - , - O(C 1 -C 3烷基) - ; - (C 1 -C 3烷基)O-; -C(O) - ; -C(= N-O(C 1 -C 3烷基)) - ; -NH-或-NH(C 1 -C 3烷基) - ; Ar是任选被一个或多个选自卤素,三氟甲基,三氟甲氧基,甲基,-NH(C 1 -C 3烷基) - 的取代基取代的苯基。 -N(C 1 -C 3烷基)(C 1 -C 3烷基) - ,含有一个与Ar共价结合的氮原子的5至7元杂环,并任选地含有一个或两个选自N,O和S的杂原子; 和含有1至3个选自S,O e N的杂原子的5或6元杂芳环,所述杂芳环被一个或两个选自(C 1 -C 3)烷基,(C 3 -C 5) )环烷基氧基,(C1-C3)烷基羰基。 本发明的化合物可用于制备用于治疗需要使用EP4受体拮抗剂的病症的药物,例如治疗急性和慢性疼痛,炎性疼痛,骨关节炎,炎症相关疾病作为关节炎 ,类风湿性肾炎,癌症,子宫内膜异位症和偏头痛。